Nautilus logo

MDMA-Assisted Therapy in the Media

By Maya Singer

February 12, 2021

VOGUE Magazine

"...MDMA—may help alleviate the isolation brought on by COVID. It may also play a role in helping the people hardest hit by the pandemic recuperate: Nautilus Sanctuary, a nonprofit psychedelics-­research and training center in New York, is already planning a study exploring the use of MDMA to treat frontline workers with severe PTSD—one of the many inquiries to expand on the drug’s groundbreaking FDA trials sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS), which entered phase three in 2017."



Painting by Jeanette Mundt, My Lee Reynold’s Mushrooms, 2016, oil on canvas, 24 x 18 in.

Courtesy of the artist and The Green Gallery, Milwaukee.

image
MAPS logo

MAPS' Phase III clinical trials using MDMA-assisted therapy for moderate to severe PTSD

Ongoing Study

MDMA-assisted therapy as a treatment for Post Traumatic Stress in COVID-19 Frontline Healthcare Workers


Learn More & Support

Upcoming Study

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers

Nautilus Sanctuary receives FDA Approval for an Investigator-Initiated Clinical Trial in the use of MDMA-assisted therapy to treat symptoms of post-traumatic stress and burnout in NYC-area healthcare workers affected by their response to the COVID pandemic. 

Share by: